関連する実験動画
Updated: Jun 25, 2026
08:37
Isolation, Fixation, and Immunofluorescence Imaging of Mouse Adrenal Glands
Published on: October 2, 2018
ANGIOTENSIN II: コルチコイド産生に及ぼす影響 鶏の副腎細胞による
Science (New York, N.Y.)
|September 27, 1963
まとめ
鶏の腎上腺は,哺乳類のコルチコトロプホルモン (ACTH) によって刺激されたときにコルチコイドを生成します. しかし,哺乳類のアンジオテンシンIIは,試験管内でのコルチコイド産生に影響を与えず,種特有のホルモン調節を示唆した.
科学分野:
- 比較内分泌学とは
- 鳥類の生理学 鳥類の生理学
- ステロイド生成 (ステロイドゲネシス)
背景:
- レニン-アニオテンシン系 (RAS) は,哺乳類における血圧と電解質バランスの調節に重要な役割を果たします.
- アンジオテンシンIIの機能と,鳥類の腎上腺との相互作用はあまり理解されていない.
- アドレノ皮質のステロイド生成は,生理学的ホメオスタシスに不可欠です.
研究 の 目的:
- 鶏の腎上腺組織におけるコルチコイド産生に対する哺乳類のアンジオテンシンIIの効果を研究する.in vitro.
- 哺乳類のアンジオテンシンIIとコルチコトロプホルモン (ACTH) に対する鶏の腎上腺組織の反応性を比較する.
主な方法:
- 鶏の腎上腺組織のインキュベーション in vitro.
- 哺乳類のアンジオテンシンIIを化媒質に添加する.
- 哺乳類のコルチコトロプホルモン (ACTH) を化媒質に添加する.
- アルドステロンとコルチコステロンの産生を測定する.
主要な成果:
- 哺乳類のアンジオテンシンIIは,鶏の腎上腺組織によるコルチコイド産生 (アルドステロンおよびコルチコステロン) を刺激しなかった.
- 哺乳類のコルチコトロプホルモン (ACTH) は,アルドステロンとコルチコステロンの両方の生産を著しく刺激しました.
結論:
- 鶏の腎上腺組織は,哺乳類のアンジオテンシンIIにインビトロ反応しない.
- 鶏の腎上腺組織は哺乳類のACTHに反応し,ACTH媒介のステロイド生成の保存経路を示しています.
- これらの発見は,哺乳類と鳥類の間でレニン-アンジオテンシン系と腎上腺機能の調節の違いを示唆しています.
関連する概念動画
01:31Hormones of the Adrenal Glands
Adrenal hormones play a pivotal role in maintaining the body's electrolyte balance and orchestrating responses to stress, showcasing the intricate functions of the adrenal cortex and medulla.
The adrenal cortex, a powerhouse of hormone synthesis, generates over two dozen corticosteroid hormones. The zona glomerulosa produces mineralocorticoids, exemplified by aldosterone, influencing the electrolyte composition of body fluids. The synthesis of glucocorticoids such as cortisol and corticosterone...
The adrenal cortex, a powerhouse of hormone synthesis, generates over two dozen corticosteroid hormones. The zona glomerulosa produces mineralocorticoids, exemplified by aldosterone, influencing the electrolyte composition of body fluids. The synthesis of glucocorticoids such as cortisol and corticosterone...
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
01:25Antihypertensive Drugs: Direct Renin Inhibitors
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:19Cushing Syndrome II: Pathophysiology
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...